A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder
Journal of Affective Disorders · 2025-12 · 391 · 119949
DOI: 10.1016/j.jad.2025.119949 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025-12. Verfasst von Sai Sailesh Kumar Goothy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Indian Center of Neurophysiology, Andhra Pradesh, India; NRI Institute of Medical Sciences, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Major Depressive Disorder, Electric Stimulation Therapy, Vestibular Nerve. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
AIMS AND OBJECTIVES: Stimulating the vestibular nerve may influence neurological processes such as prefrontal cortex functions, aiding cognitive flexibility and emotional regulation, important aspects of addressing depressive patterns. This randomized, double-blind, sham-controlled trial aimed to determine the efficacy and safety of a non-invasive electrical vestibular nerve stimulation (VeNS) device as a treatment for major depressive disorder (MDD). MATERIALS AND METHODS: 62 adults (mean age = 43.1 ± 5.0 years) with MDD were randomized to receive an active VeNS device (n = 31) or a sham device (n = 31). Both groups attended the clinic for stimulation sessions (30 min) 5 days per week. The primary outcome was change in Beck's Depression Inventory (BDI-II) score from baseline to week 8. Secondary outcomes were change in Insomnia Severity Index (ISI), Generalized Anxiety Disorder, 7-item (GAD-7), and the EQ-5D-5L Health Utility Index (HUI) scores from baseline to week 8. A post-intervention follow-up was at week 12. RESULTS: After 8 weeks, the active group showed a mean BDI-II score reduction of 6.39 points greater than the sham group (P < 0.001), with scores remaining low during the 4-week post-intervention follow-up. Additionally, the active group, compared with the sham group, showed a significant improvement in ISI (-6.29 vs. 2.23, p < 0.001), GAD-7 (-4.45 vs. -0.32, p < 0.001) and HUI (0.51 vs 0.11, p < 0.001) One minor Adverse Event was reported in the sham group. Formal blinding assessment demonstrated a successful level of blinding was achieved throughout the study. CONCLUSION: VeNS, when delivered over 8-weeks, appears to have a clinically meaningful benefit as an intervention for major depressive disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Indian Center of Neurophysiology, Andhra Pradesh, India; NRI Institute of Medical Sciences, Andhra Pradesh, India.
- NRI Institute of Medical Sciences, Andhra Pradesh, India.
- Neurovalens Ltd., Belfast, United Kingdom. Electronic address: joe.reel@neurovalens.com.
- Neurovalens Ltd., Belfast, United Kingdom.
- Neurovalens Ltd., Belfast, United Kingdom; Dept. of Neurosurgery, Standford University, Palo Alto, USA; School of Medicine, Ulster University, Magee, United Kingdom.
Zitieren
APA
Goothy, S. S. K., Singh, R., Reel, J., Robinson, R., Ratajczak, W., Watson, S., & McKeown, J. (2025). A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder. Journal of Affective Disorders, 391, 119949. https://doi.org/10.1016/j.jad.2025.119949
Vancouver
Goothy SSK, Singh R, Reel J, Robinson R, Ratajczak W, Watson S, et al. A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder. Journal of Affective Disorders. 2025;391:119949. doi:10.1016/j.jad.2025.119949
BibTeX
@article{Goothy2025,
author = {Goothy, Sai Sailesh Kumar and Singh, Rohit and Reel, Joseph and Robinson, Rachel and Ratajczak, Wiktoria and Watson, Sinead and McKeown, Jason},
title = {A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder},
journal = {Journal of Affective Disorders},
year = {2025},
volume = {391},
pages = {119949},
doi = {10.1016/j.jad.2025.119949}
}
EUVIMED